chr17-58724105-G-A
Variant summary
Our verdict is Pathogenic. The variant received 15 ACMG points: 15P and 0B. PS3PM2PP3PP5_Very_Strong
The NM_058216.3(RAD51C):c.965+5G>A variant causes a splice region, intron change. The variant allele was found at a frequency of 0.00000137 in 1,456,128 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★). ClinVar reports functional evidence for this variant: "SCV000550196: Studies have shown that this variant alters mRNA splicing and is expected to lead to the loss of protein expression (PMID:22725699, 33011440, 33333735).; SCV000663788: Functional RNA studies have demonstrated that this alteration results in out-of-frame exon skipping and premature protein truncation (Coulet F et al. Clin. Genet. 2013 Apr;83:332-6; Sanoguera-Miralles L et al. Cancers (Basel), 2020 Dec;12; Ambry internal data).; SCV000686408: RNA studies using RT-PCR analysis of a patient sample and mini-gene assays have shown that this variant causes out-of-frame skipping of exon 7 (PMID:22725699, 33011440, 33333735), which is expected to create a frameshift and premature translation stop signal resulting in an absent or non-functional protein product.; SCV005896248: Functional studies indicate this variant impacts protein function [PMID:37444530, 33011440, 22725699, 39299233].".
Frequency
Consequence
NM_058216.3 splice_region, intron
Scores
Clinical Significance
Conservation
Publications
- RAD51C-related cancer predispositionInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- breast-ovarian cancer, familial, susceptibility to, 3Inheritance: AD Classification: STRONG, LIMITED Submitted by: Genomics England PanelApp, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- Fanconi anemia complementation group OInheritance: AR Classification: STRONG, MODERATE, LIMITED Submitted by: Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae), G2P
- hereditary breast ovarian cancer syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Fanconi anemiaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 15 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_058216.3. You can select a different transcript below to see updated ACMG assignments.
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| RAD51C | TSL:1 MANE Select | c.965+5G>A | splice_region intron | N/A | ENSP00000336701.4 | O43502-1 | |||
| RAD51C | TSL:1 | n.*393+5G>A | splice_region intron | N/A | ENSP00000433332.1 | Q7KZJ0 | |||
| RAD51C | c.1067+5G>A | splice_region intron | N/A | ENSP00000600482.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD2 exomes AF: 0.00000398 AC: 1AN: 251118 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1456128Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 724664 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 32
ClinVar
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at